Clinical Trials Logo

HPV16 Positive clinical trials

View clinical trials related to HPV16 Positive.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00988559 Completed - HPV16 Positive Clinical Trials

Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)

Start date: September 2009
Phase: Phase 1
Study type: Interventional

This study will test the efficacy and safety of different routes of administration of a DNA vaccine in patients with HPV16+ CIN2/3. Subjects will be enrolled in one of six treatment groups. Subjects enrolled in the first two groups will receive vaccination intradermally with a needle-free delivery device. Subjects enrolled in groups 3 and 4 will receive vaccination intramuscularly. Subjects enrolled in groups 5 and 6 will receive vaccine intralesionally.